{"key":"tb-500-fragment","slug":"tb-500-fragment","name":"TB-500 Fragment","other_names":["TB-500 FRAG"],"kind":"single","area":{"slug":"repair","name":"Repair and recovery"},"classification":"Fragment of thymosin beta-4","standing":{"id":"preclinical","label":"Animal and cell studies","rank":1},"summary":"A short fragment of thymosin beta-4 containing its actin-binding region.","cas_number":null,"molecular_formula":null,"molecular_weight":null,"components":[],"has_article":false,"pubmed":{"papers":161,"in_humans":75,"clinical_trials":2},"retired":false,"updated_at":"2026-11-18T00:17:24.691Z","url":"https://pepts.wiki/compounds/tb-500-fragment","article":null,"evidence":{"query":"(\"Ac-SDKP\"[tiab] OR \"thymosin beta-4 fragment\"[tiab])","fetched_at":"2026-11-16T23:07:50.911Z","counts":{"rcts":1,"human":75,"total":161,"reviews":27,"clinicalTrials":2},"years":[{"year":2012,"count":11},{"year":2013,"count":12},{"year":2014,"count":10},{"year":2015,"count":11},{"year":2016,"count":8},{"year":2017,"count":1},{"year":2018,"count":13},{"year":2019,"count":11},{"year":2020,"count":6},{"year":2021,"count":6},{"year":2022,"count":8},{"year":2023,"count":8},{"year":2024,"count":1},{"year":2025,"count":8},{"year":2026,"count":8}],"top":[{"doi":"10.1371/journal.pone.0143338","url":"https://pubmed.ncbi.nlm.nih.gov/26656271/","kind":"meta","pmid":"26656271","year":2015,"title":"The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels: A Systematic Review and Meta-Analysis","venue":"PloS one","authors":"Mnguni AT, Engel ME, Borkum MS, et al."},{"doi":"10.3760/cma.j.cn121094-20211115-00565","url":"https://pubmed.ncbi.nlm.nih.gov/37248179/","kind":"meta","pmid":"37248179","year":2023,"title":"[Meta-analysis of Ac-SDKP inhibition of Pulmonary fibrosis in animal models]","venue":"Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases","authors":"Gong HB, Zhang CM, Tang XY, et al."},{"doi":"10.1172/JCI118484","url":"https://pubmed.ncbi.nlm.nih.gov/8609242/","kind":"trial","pmid":"8609242","year":1996,"title":"Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline","venue":"The Journal of clinical investigation","authors":"Azizi M, Rousseau A, Ezan E, et al."},{"doi":"10.1111/jch.14206","url":"https://pubmed.ncbi.nlm.nih.gov/33694311/","kind":"rct","pmid":"33694311","year":2021,"title":"Angiotensin-converting enzyme inhibitors increase anti-fibrotic biomarkers in African Americans with left ventricular hypertrophy","venue":"Journal of clinical hypertension (Greenwich, Conn.)","authors":"A Romero C, Mathew S, Wasinski B, et al."},{"doi":"10.1196/annals.1415.018","url":"https://pubmed.ncbi.nlm.nih.gov/17468232/","kind":"review","pmid":"17468232","year":2007,"title":"beta-Thymosins","venue":"Annals of the New York Academy of Sciences","authors":"Hannappel E"},{"doi":"10.1016/j.intimp.2022.109628","url":"https://pubmed.ncbi.nlm.nih.gov/36580759/","kind":"study","pmid":"36580759","year":2023,"title":"Thymosin β4 and the anti-fibrotic switch","venue":"International immunopharmacology","authors":"Kleinman HK, Kulik V, Goldstein AL"},{"doi":"10.1016/j.mce.2021.111254","url":"https://pubmed.ncbi.nlm.nih.gov/33798633/","kind":"review","pmid":"33798633","year":2021,"title":"Renin-angiotensin system and inflammation update","venue":"Molecular and cellular endocrinology","authors":"Cantero-Navarro E, Fernández-Fernández B, Ramos AM, et al."},{"doi":"10.1371/journal.pone.0226553","url":"https://pubmed.ncbi.nlm.nih.gov/31877149/","kind":"study","pmid":"31877149","year":2019,"title":"Tissue ACE phenotyping in lung cancer","venue":"PloS one","authors":"Danilov SM, Metzger R, Klieser E, et al."},{"doi":"10.3389/fphar.2023.1252315","url":"https://pubmed.ncbi.nlm.nih.gov/37614315/","kind":"study","pmid":"37614315","year":2023,"title":"Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms","venue":"Frontiers in pharmacology","authors":"Bhatia D, Srivastava SP"},{"doi":"10.1007/s00011-018-1208-x","url":"https://pubmed.ncbi.nlm.nih.gov/30560372/","kind":"review","pmid":"30560372","year":2019,"title":"Antiinflammatory peptides: current knowledge and promising prospects","venue":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","authors":"Dadar M, Shahali Y, Chakraborty S, et al."}]},"library_version":"183:2026-11-17T11:05:42.386Z","attribution":"Data from Pepts.wiki (https://pepts.wiki), CC BY 4.0. Link back to the compound's page.","notice":"We are not doctors, and nothing on Pepts.wiki is medical advice or a recommendation to use anything. The wiki sets out what studies measured, as clearly and evenly as it can, so you can make better-informed decisions. Always consult a medical professional before acting on anything you read here."}